Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine vBMD in Glucocorticoid-Induced Osteoporosis in Men

NCT00503399 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00503399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00503399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine vBMD in Glucocorticoid-Induced Osteoporosis in Men
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2007
Completion date
October 31, 2010
Enrollment
92 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis